Development of Programs to Predict the Occurrence of Mucositis from Digital Imaging and Communications in Medicine Data by Machine Learning in Head and Neck Volumetric Modulated Radiotherapy

Overview

Journal J Appl Clin Med Phys

Specialties Biophysics
General Medicine

Date 2023 Aug 21

PMID 37602786

Authors

Toshiya Rachi

Takaki Ariji

Shinichi Takahashi

Affiliations

Soon will be listed here.

Abstract

Volumetric modulated arc therapy (VMAT) with cisplatin for head and neck cancer is often accompanied by symptoms of pharyngeal and oral mucositis. However, no standard medical program exists for the prevention and treatment of mucositis, and the mechanisms of mucositis have not yet been fully proven. Therefore, adaptive radiotherapy (ART), which is a re-planning process, is administered when severe mucositis develops during the treatment period. We extracted the treatment plans of patients who developed severe mucositis from DICOM data and used machine learning to determine its quantitative features. This study aimed to develop a machine learning program that can predict the development of mucositis requiring ART. This study included 61 patients who received concurrent chemotherapy and radiotherapy (RT). For each patient, the equivalent square field size of each segmental irradiation field used for VMAT, dose per segment (Gy), clinical target volume high, and mean dose of the oral cavity (Gy) were calculated. Furthermore, 671 five-dimensional lists were generated from the acquired data. Support vector machine (SVM) and K-nearest neighbor (KNN) were used for machine learning. For the accuracy score, the test size was varied from 10% to 90%, and the random number of data extracted in each test size was further varied from 1 to 100 to calculate a mean accuracy score. The mean accuracy scores of SVM and KNN were 0.981 ± 0.020 and 0.972 ± 0.033, respectively. The presence or absence of ART for mucositis was classified with high accuracy. The classification of the five-dimensional list was implemented with high accuracy, and a program was constructed to predict the onset of mucositis requiring ART before treatment began. This study suggests that it may support preventive measures against mucositis and the completion of RT without having to re-plan.

Citing Articles

Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications.

Broggi G, Maniaci A, Lentini M, Palicelli A, Zanelli M, Zizzo M Cancers (Basel). 2024; 16(21).

PMID: 39518063 PMC: 11545333. DOI: 10.3390/cancers16213623.

Development of programs to predict the occurrence of mucositis from digital imaging and communications in medicine data by machine learning in head and neck volumetric modulated radiotherapy.

Rachi T, Ariji T, Takahashi S J Appl Clin Med Phys. 2023; 24(12):e14125.

PMID: 37602786 PMC: 10691621. DOI: 10.1002/acm2.14125.

References

Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk J . Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2013; 110(1):172-81. DOI: 10.1016/j.radonc.2013.10.010. View

Scully C, Epstein J . Oral health care for the cancer patient. Eur J Cancer B Oral Oncol. 1996; 32B(5):281-92. DOI: 10.1016/0964-1955(96)00037-1. View

Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J . Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol. 2011; 100(1):33-40. DOI: 10.1016/j.radonc.2011.05.036. View

Sonis S . Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009; 45(12):1015-20. DOI: 10.1016/j.oraloncology.2009.08.006. View

Wang Z, Zhang S, Zhang Z, Zhang C, Hu H, Tu W . Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. Laryngoscope. 2012; 122(2):291-8. DOI: 10.1002/lary.22434. View

Naidu M, Ramana G, Rani P, Krishna Mohan I, Suman A, Roy P . Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. Neoplasia. 2004; 6(5):423-31. PMC: 1531648. DOI: 10.1593/neo.04169. View

Figen M, Oksuz D, Duman E, Prestwich R, Dyker K, Cardale K . Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice. Front Oncol. 2020; 10:579917. PMC: 7690320. DOI: 10.3389/fonc.2020.579917. View

Krishnappan C, Anu Radha C, Balaji K, Mani P, Subramani V, Thanigaimalai V . Evaluation of beam matching accuracy among six linacs from the same vendor. Radiol Phys Technol. 2018; 11(4):423-433. DOI: 10.1007/s12194-018-0480-3. View

Bechtel A, Indelicato D, Sandler E . Enteral Nutrition in Pediatric High-risk Head and Neck Cancer Patients Receiving Proton Therapy: Identifying Risk Factors and Quality of Life Concerns to Optimize Care. J Pediatr Hematol Oncol. 2019; 41(4):e247-e253. DOI: 10.1097/MPH.0000000000001364. View

10.

Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C . The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). Radiother Oncol. 2018; 130:25-31. DOI: 10.1016/j.radonc.2018.06.032. View

11.

Zhao J, Zheng H, Li L, Zhang L, Zhao Y, Jiang N . Predictors for Weight Loss in Head and Neck Cancer Patients Undergoing Radiotherapy: A Systematic Review. Cancer Nurs. 2015; 38(6):E37-45. DOI: 10.1097/NCC.0000000000000231. View

12.

Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S . Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2018; 2(4):230-243. PMC: 5829945. DOI: 10.1136/svn-2017-000101. View

13.

Moslemi D, Nokhandani A, Otaghsaraei M, Moghadamnia Y, Kazemi S, Moghadamnia A . Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature. Radiother Oncol. 2016; 120(1):13-20. DOI: 10.1016/j.radonc.2016.04.001. View

14.

Lalla R, Bowen J, Barasch A, Elting L, Epstein J, Keefe D . MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014; 120(10):1453-61. PMC: 4164022. DOI: 10.1002/cncr.28592. View

15.

Huang S, Cai N, Pacheco P, Narrandes S, Wang Y, Xu W . Applications of Support Vector Machine (SVM) Learning in Cancer Genomics. Cancer Genomics Proteomics. 2017; 15(1):41-51. PMC: 5822181. DOI: 10.21873/cgp.20063. View

16.

Rachi T, Ariji T, Takahashi S . Development of programs to predict the occurrence of mucositis from digital imaging and communications in medicine data by machine learning in head and neck volumetric modulated radiotherapy. J Appl Clin Med Phys. 2023; 24(12):e14125. PMC: 10691621. DOI: 10.1002/acm2.14125. View

17.

Yoosuf A, Ahmad M, Alshehri S, Alhadab A, Alqathami M . Investigation of optimum minimum segment width on VMAT plan quality and deliverability: A comprehensive dosimetric and clinical evaluation using DVH analysis. J Appl Clin Med Phys. 2021; 22(11):29-40. PMC: 8598144. DOI: 10.1002/acm2.13417. View

18.

Narayan S, Lehmann J, Coleman M, Vaughan A, Yang C, Enepekides D . Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 72(3):756-62. DOI: 10.1016/j.ijrobp.2008.01.060. View

19.

Atiya A . Estimating the posterior probabilities using the k-nearest neighbor rule. Neural Comput. 2005; 17(3):731-40. DOI: 10.1162/0899766053019971. View

20.

Elting L, Cooksley C, Chambers M, Garden A . Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007; 68(4):1110-20. DOI: 10.1016/j.ijrobp.2007.01.053. View